Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-02

Clinical Trial Update: Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating subanesthetic concentrations of isoflurane and nitrous oxide in individuals with opioid use disorder and substance use disor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrous oxide (nitrous oxide)
  • isoflurane (isoflurane)

Snippet

Sponsor: University of Chicago | Conditions: Opioid-Related Disorders, Substance-Related Disorders | Phase 2 | Status: COMPLETED